maliqun61 schreef op 28 augustus 2020 17:02:
Wordt druk in 2021
- Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 (June 2021)
- Patient Registry to Evaluate the Real-world Safety of Ruconest® (July 16, 2021)
- C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks (June 2021)
- Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 (March 15, 2021)
- RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function (December 2020 )
- A Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions (March 2020)
clinicaltrials.gov/ct2/results?term=c...